Estradiol undecylate/norethisterone enanthate

Estradiol undecylate/norethisterone enanthate (EU/NETE) is a combination medication of estradiol undecylate (EU), an estrogen, and norethisterone enanthate (NETE), a progestin, which was developed by Schering for potential use as a combined injectable contraceptive in women but was ultimately never marketed.^{[1][2][3][4][5][6]} It contained 5 to 10 mg EU and 50 to 70 mg NETE in oil solution and was intended for use by intramuscular injection at regular intervals.^{[1][2][3][4][5][6]} Although never commercialized, EU/NETE was found to be effective and well tolerated.^{[1][2][3][4][5][6]}

Estradiol undecylate /
norethisterone enanthate

Estradiol undecylate (top) and norethisterone enanthate (bottom)
Combination of
Estradiol undecylate	Estrogen
Norethisterone enanthate	Progestogen
Clinical data
Other names	EU/NETE
Routes of administration	Intramuscular injection

See also

• Polyestradiol phosphate/medroxyprogesterone acetate
• List of combined sex-hormonal preparations § Estrogens and progestogens